Skip to main content
. 2013 Aug 15;8(23):2144–2154. doi: 10.3969/j.issn.1673-5374.2013.23.004

Figure 2.

Figure 2

Scatter diagram analyses of the relationships between decreased levels of C-reactive protein (CRP), fibrinogen (Fg), and D-dimer (DD); and decreased levels of low-density lipoprotein cholesterol (LDL-C) and total cholesterol (TC) in the study group after 4 weeks of treatment with atorvastatin.

There were no significant correlations between decreased levels of markers of inflammation and thrombogenesis, and decreased levels of markers of hyperlipidemia (A–F; rank correlation test).